Real-world effect of monoclonal antibody treatment in COVID-19 patients in a diverse population in the United States

K Rainwater-Lovett, JT Redd, MA Stewart… - Open Forum …, 2021 - academic.oup.com
Background Monoclonal antibodies (mAbs) against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are a promising treatment for limiting the progression of …

Modelling supraglacial debris-cover evolution from the single-glacier to the regional scale: an application to High Mountain Asia

L Compagno, M Huss, ES Miles, MJ McCarthy… - The …, 2022 - tc.copernicus.org
Currently, about 12 %–13 % of High Mountain Asia’s glacier area is debris-covered, which
alters its surface mass balance. However, in regional-scale modelling approaches, debris-…

[HTML][HTML] An Implementation Strategy to Develop Sustainable Surveillance Activities Through Adoption of a Target Operating Model

NK Lee, MA Stewart, JS Dymond… - Frontiers in Public Health, 2022 - frontiersin.org
The increasing threat of emerging and re-emerging pathogens calls for a shared vision
toward developing and maintaining global surveillance mechanisms to enable rapid …

Staffing and capacity planning for SARS-CoV-2 monoclonal antibody infusion facilities: a performance estimation calculator based on discrete-event simulations

Ç Çaglayan, J Thornhill, MA Stewart… - Frontiers in Public …, 2022 - frontiersin.org
Background The COVID-19 pandemic has significantly stressed healthcare systems. The
addition of monoclonal antibody (mAb) infusions, which prevent severe disease and reduce …

Implementation of SARS-CoV-2 monoclonal antibody infusion sites at three medical centers in the United States: strengths and challenges assessment to inform …

AS Lambrou, JT Redd, MA Stewart… - Disaster Medicine and …, 2023 - cambridge.org
Monoclonal antibody therapeutics to treat coronavirus disease (COVID-19) have been
authorized by the US Food and Drug Administration under Emergency Use Authorization (EUA). …

Expert recommendations on the management of hypertension in patients with ovarian and cervical cancer receiving bevacizumab in the UK

…, G Shaikh, M Stewart, L Buckley, T Miles… - British journal of …, 2019 - nature.com
Bevacizumab is an anti-vascular endothelial growth factor monoclonal antibody that may
prolong survival in ovarian and cervical cancer when given in combination with chemotherapy. …

Outcomes for residential or inpatient intensive treatment of obsessive–compulsive disorder: a systematic review and meta-analysis

…, I Naismith, S Miles, LJ Gledhill, G Stewart… - Journal of Obsessive …, 2016 - Elsevier
Little data exist to inform the treatment of severe or treatment refractory obsessive–compulsive
disorder (OCD) in an inpatient or residential setting. We aimed to determine effect size of …

Anxiety sensitivity and PTSD symptom severity are reciprocally related: evidence from a longitudinal study of physical trauma survivors.

GN Marshall, JNV Miles, SH Stewart - Journal of abnormal …, 2010 - psycnet.apa.org
Cross-lagged panel analysis of interview data collected from survivors of traumatic physical
injury (N= 677) was used to examine the temporal relationship between anxiety sensitivity …

Sacrococcygeal teratomas in adult.

RM Miles, GS Stewart Jr - Annals of surgery, 1974 - ncbi.nlm.nih.gov
Eleven sacrococcygeal teratomas in adults which were surgically treated from 1952 to 1972
were reviewed. All were benign, and all but one occurred in females. Pain and drainage …

Evaluating methods for isolating total RNA and predicting the success of sequencing phylogenetically diverse plant transcriptomes

…, D Soltis, P Soltis, D Stevenson, CN Stewart Jr… - PloS one, 2012 - journals.plos.org
Next-generation sequencing plays a central role in the characterization and quantification of
transcriptomes. Although numerous metrics are purported to quantify the quality of RNA, …